Average intermittent access infusions from days 12-15 minus average from days 1-3
Tags: Behavior · Intermittent access · Cocaine
Project: p50_paul_meyer_2020
1 locus · 1 gene with independent associations · 1 total associated gene
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr8 | 33211184 | 34601262 | 1 | 1 | 1.07e-08 | 1.88e-03 | 1.06e-01 | Ddx25 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1 |
Adipose | alternative TSS | 0 | 0 | 1 |
Adipose | gene expression | 1 | 0 | 0.99 |
Adipose | isoform ratio | 0 | 0 | 0.96 |
Adipose | intron excision ratio | 0 | 0 | 1 |
Adipose | mRNA stability | 0 | 0 | 0.97 |
BLA | alternative polyA | 0 | 0 | 1 |
BLA | alternative TSS | 0 | 0 | 0.99 |
BLA | gene expression | 0 | 0 | 0.99 |
BLA | isoform ratio | 0 | 0 | 0.96 |
BLA | intron excision ratio | 0 | 0 | 0.97 |
BLA | mRNA stability | 0 | 0 | 0.97 |
Brain | alternative polyA | 0 | 0 | 1.01 |
Brain | alternative TSS | 0 | 0 | 1.01 |
Brain | gene expression | 0 | 0 | 1 |
Brain | isoform ratio | 0 | 0 | 0.98 |
Brain | intron excision ratio | 0 | 0 | 0.99 |
Brain | mRNA stability | 0 | 0 | 0.98 |
Eye | alternative polyA | 0 | 0 | 1.02 |
Eye | alternative TSS | 0 | 0 | 1.12 |
Eye | gene expression | 0 | 0 | 0.98 |
Eye | isoform ratio | 0 | 0 | 1.17 |
Eye | intron excision ratio | 0 | 0 | 1.09 |
Eye | mRNA stability | 0 | 0 | 1.14 |
IL | alternative polyA | 0 | 0 | 0.95 |
IL | alternative TSS | 0 | 0 | 1.01 |
IL | gene expression | 0 | 0 | 0.99 |
IL | isoform ratio | 0 | 0 | 0.99 |
IL | intron excision ratio | 0 | 0 | 0.97 |
IL | mRNA stability | 0 | 0 | 0.95 |
LHb | alternative polyA | 0 | 0 | 1.03 |
LHb | alternative TSS | 0 | 0 | 1.1 |
LHb | gene expression | 0 | 0 | 1.01 |
LHb | isoform ratio | 0 | 0 | 0.95 |
LHb | intron excision ratio | 0 | 0 | 0.94 |
LHb | mRNA stability | 0 | 0 | 0.98 |
Liver | alternative polyA | 0 | 0 | 0.97 |
Liver | alternative TSS | 0 | 0 | 0.93 |
Liver | gene expression | 0 | 0 | 0.97 |
Liver | isoform ratio | 0 | 0 | 1 |
Liver | intron excision ratio | 0 | 0 | 0.97 |
Liver | mRNA stability | 0 | 0 | 0.96 |
NAcc | alternative polyA | 0 | 0 | 0.99 |
NAcc | alternative TSS | 0 | 0 | 1.05 |
NAcc | gene expression | 0 | 0 | 1.01 |
NAcc | isoform ratio | 0 | 0 | 1.04 |
NAcc | intron excision ratio | 0 | 0 | 0.95 |
NAcc | mRNA stability | 0 | 0 | 1.01 |
OFC | alternative polyA | 0 | 0 | 0.92 |
OFC | alternative TSS | 0 | 0 | 1.04 |
OFC | gene expression | 0 | 0 | 1 |
OFC | isoform ratio | 0 | 0 | 1.01 |
OFC | intron excision ratio | 0 | 0 | 0.95 |
OFC | mRNA stability | 0 | 0 | 0.97 |
PL | alternative polyA | 0 | 0 | 0.96 |
PL | alternative TSS | 0 | 0 | 1.04 |
PL | gene expression | 0 | 0 | 1.01 |
PL | isoform ratio | 0 | 0 | 1 |
PL | intron excision ratio | 0 | 0 | 0.97 |
PL | mRNA stability | 0 | 0 | 0.99 |
pVTA | alternative polyA | 0 | 0 | 1.01 |
pVTA | alternative TSS | 0 | 0 | 1.1 |
pVTA | gene expression | 0 | 0 | 0.99 |
pVTA | isoform ratio | 0 | 0 | 0.99 |
pVTA | intron excision ratio | 0 | 0 | 0.98 |
pVTA | mRNA stability | 0 | 0 | 1.01 |
RMTg | alternative polyA | 0 | 0 | 0.99 |
RMTg | alternative TSS | 0 | 0 | 1.16 |
RMTg | gene expression | 0 | 0 | 1.01 |
RMTg | isoform ratio | 0 | 0 | 0.96 |
RMTg | intron excision ratio | 0 | 0 | 0.93 |
RMTg | mRNA stability | 0 | 0 | 1.06 |